Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan.
Hayato TaniguchiFumihiro OgawaHiroshi HonzawaKeishi YamaguchiShoko NiidaMafumi ShinoharaKohei TakahashiMasayuki IwashitaTakeru AbeSousuke KuboMakoto KudoIchiro TakeuchiPublished in: Acute medicine & surgery (2020)
Treatment of severe pneumonia in COVID-19 by ECMO should recognize lung plasticity considering time to ECMO introduction and interstitial biomarkers. In Japan, centralization of ECMO patients has not been sufficient. Thus, we suggest nationwide centralization and further research to respond to the crisis caused by COVID-19.
Keyphrases
- extracorporeal membrane oxygenation
- coronavirus disease
- respiratory failure
- acute respiratory distress syndrome
- sars cov
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early onset
- respiratory syndrome coronavirus
- peritoneal dialysis
- prognostic factors
- intensive care unit
- cross sectional
- combination therapy
- community acquired pneumonia